Wilhelm Haas

9PUBLICATIONS
160CO-AUTHORS
Molecular targetsCancer diagnosisCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 02, 2026
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

|May 12, 2025
Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets.

Vindhya Vijay, Negin Karisani, Lei Shi

|Jul 11, 2024
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity.

Meng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula

|May 15, 2024
SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma.

Iris S Luk, Caroline M Bridgwater, Angela Yu

|Oct 28, 2022
Ribosome changes reprogram translation for chemosurvival in G0 leukemic cells.

Chandreyee Datta, Samuel S Truesdell, Keith Q Wu

|Jun 03, 2022
CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation.

Margherita Boieri, Anna Malishkevich, Ranya Guennoun

Pageof 2

Frequent Collaborators

5 joint publications

Johannes Kreuzer

2 joint publications

Meng-Ju Wu

2 joint publications

Ilaria Gritti

2 joint publications

Qin Xu